{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:49:00Z","timestamp":1795009740677,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to assess the impact of open or laparoscopic resection of primary colorectal cancer (CRC) on the development of metachronous colorectal peritoneal metastases (CPM) in a population-based cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This was a retrospective, population-based study of CRC patients who underwent open or laparoscopic resection of the primary tumour in the Netherlands between January 1st and June 30th 2015. Patients with synchronous metastases were excluded. CPM were considered metachronous if diagnosed\u2009\u2265\u200990\u00a0days after resection of primary CRC. Multivariable cox regression analysis was performed to correct for tumour location, histology, differentiation, and stage, nodal stage, tumour perforation, primary surgery type, and unclear resection margins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 1516 CRC patients underwent open resection and 3236 CRC patients underwent laparoscopic resection, with a 3-year cumulative incidence of metachronous CPM of 7.3% and 3.7%, respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), after median follow-up of 42\u00a0months. Open surgical approach was significantly associated with the development of metachronous CPM: HR 1.4 [95%CI 1.1\u20131.8]. Other prognostic factors were mucinous adenocarcinoma histology (HR 1.6, 95%CI 1.0\u20132.5), T4 stage (HR 3.2, 95%CI 2.3\u20134.5), N1 stage (HR 2.9, 95%CI 2.1\u20134.0), and N2 stage (HR 4.2, 95%CI 2.9\u20136.1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients treated with open resection had a significantly higher risk to develop metachronous CPM than patients treated with laparoscopic resection. The mechanisms underlying this phenomenon remain unknown but might be related to differences in per-operative specimen handling, tumour spill, surgical trauma and pro-inflammatory response. This finding might imply the need for a personalized follow-up after primary resection of CRC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00464-022-09041-z","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T20:02:59Z","timestamp":1642708979000},"page":"6551-6557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-0994","authenticated-orcid":false,"given":"Robin J.","family":"Lurvink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Checca","family":"Bakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery E.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"de Reuver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurriaan B.","family":"Tuynman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels F.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"9041_CR1","unstructured":"World Health Organization Global Cancer Observatory."},{"issue":"4","key":"9041_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","volume":"38","author":"YR Van Gestel","year":"2014","unstructured":"Van Gestel YR, de Hingh IH, van Herk-Sukel MP, van Erning FN, Beerepoot LV, Wijsman JH et al (2014) Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol 38(4):448\u2013454","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"9041_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG Van der Geest","year":"2015","unstructured":"Van der Geest LG, Lam-Boer J, Koopman M, Verhoef C, Elferink MA, de Wilt JH (2015) Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis 32(5):457\u2013465","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"9041_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","volume":"47","author":"RJ Lurvink","year":"2020","unstructured":"Lurvink RJ, Bakkers C, Rijken A, van Erning FN, Nienhuijs SW, Burger JW et al (2020) Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol 47(5):1026\u20131033","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"9041_CR5","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15(9):2426\u20132432","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"9041_CR6","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737\u20133743","journal-title":"J Clin Oncol"},{"issue":"9","key":"9041_CR7","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Goere","year":"2015","unstructured":"Goere D, Souadka A, Faron M, Cloutier AS, Viana B, Honore C et al (2015) Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22(9):2958\u20132964","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9041_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejso.2014.01.013","volume":"40","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel Y, Aalbers AGJ, van Oudheusden TR, Wegdam JA, Lemmens V et al (2014) Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open surgery in patients with colorectal cancer. Eur J Surg Oncol 40(5):511\u2013514","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"9041_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.surg.2020.02.026","volume":"168","author":"H Nagata","year":"2020","unstructured":"Nagata H, Kawai K, Hata K, Tanaka T, Nozawa H, Ishihara S (2020) Laparoscopic surgery for T4 colon cancer: a risk factor for peritoneal recurrences? Surgery 168(1):119\u2013124","journal-title":"Surgery"},{"issue":"1","key":"9041_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1470-2045(08)70310-3","volume":"10","author":"M Buunen","year":"2009","unstructured":"Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J et al (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10(1):44\u201352","journal-title":"Lancet Oncol"},{"issue":"11","key":"9041_CR11","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/bjs.7160","volume":"97","author":"DG Jayne","year":"2010","unstructured":"Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ (2010) Five-year follow-up of the Medical Research Council CLASSIC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 97(11):1638\u20131645","journal-title":"Br J Surg"},{"issue":"6","key":"9041_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.10723","volume":"105","author":"G Passot","year":"2018","unstructured":"Passot G, Dumont F, Go\u00e9r\u00e9 D, Arvieux C, Rousset P, Regimbeau JM et al (2018) Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG RENAPE). Br J Surg 105(6):663\u2013667","journal-title":"Br J Surg"},{"issue":"1","key":"9041_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/bjs.7258","volume":"98","author":"M Pascual","year":"2011","unstructured":"Pascual M, Alonso S, Par\u00e9s D, Courtier R, Gil MJ, Grande L, Pera M (2011) Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoscopic curative resection for colonic cancer. Br J Surg 98(1):50\u201359","journal-title":"Br J Surg"},{"issue":"1","key":"9041_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jss.2010.05.046","volume":"164","author":"T Sammour","year":"2010","unstructured":"Sammour T, Kahokehr A, Chan S, Booth RJ, Hill AG (2010) The humoral response after laparoscopic versus open colorectal surgery: a meta-analysis. J Surg Res 164(1):28\u201337","journal-title":"J Surg Res"},{"key":"9041_CR15","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.2147\/OTT.S93420","volume":"8","author":"IY Kim","year":"2015","unstructured":"Kim IY, Kim BR, Kim HS, Kim YW (2015) Differences in clinical features between laparoscopy and open resection for primary tumour in patients with stage IV colorectal cancer. Onco Targets Ther 8:3441\u20133448","journal-title":"Onco Targets Ther"},{"issue":"10","key":"9041_CR16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CE Klaver","year":"2019","unstructured":"Klaver CE, Wisselink DD, Punt CJA et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 4(10):761\u2013770","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"9041_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","volume":"21","author":"D Go\u00e9r\u00e9","year":"2020","unstructured":"Go\u00e9r\u00e9 D, Glehen O, Quenet F et al (2020) Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. Lancet Oncol 21(9):1147\u20131154","journal-title":"Lancet Oncol"},{"issue":"2","key":"9041_CR18","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1002\/bjs.10788","volume":"105","author":"I Ubink","year":"2018","unstructured":"Ubink I, van Eden WJ, Snaebjornsson P et al (2018) Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. Br J Surg 105(2):e204\u2013e211","journal-title":"Br J Surg"},{"key":"9041_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41418-017-0011-5","volume":"2593","author":"JF Linnekamp","year":"2018","unstructured":"Linnekamp JF, Hooff SRV, Prasetyanti PR et al (2018) Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models. Cell Death Differ 2593:616\u2013633","journal-title":"Cell Death Differ"},{"issue":"Suppl 1","key":"9041_CR20","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.21037\/jgo-20-133","volume":"12","author":"C Bakkers","year":"2021","unstructured":"Bakkers C, Simkens GAAM, De Hingh IHJT (2021) Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research. J Gastrointest Oncol 12(Suppl 1):S206\u2013S213","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"9041_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/bjs.11206","volume":"106","author":"I Ubink","year":"2019","unstructured":"Ubink I, Bolhaqueiro ACF, Elias SG et al (2019) Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg 106(10):1404\u20131414","journal-title":"Br J Surg"},{"key":"9041_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.32750","volume":"147","author":"KD Van der Willik","year":"2019","unstructured":"Van der Willik KD, Ruiter R, van Rooij FJA, Verkroost-van Heemst J, Hogewoning SJ, Timmermans K et al (2019) Ascertainment of cancer in longitudinal research: the concordance between the Rotterdam study and the Netherlands Cancer Registry. Int J Cancer 147:633\u2013640","journal-title":"Int J Cancer"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09041-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-022-09041-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09041-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T17:10:36Z","timestamp":1661361036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-022-09041-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["9041"],"URL":"https:\/\/doi.org\/10.1007\/s00464-022-09041-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Robin J. Lurvink, Anouk Rijken, Checca Bakkers, Valery E. Lemmens, Philip R. de Reuver, Jurriaan B. Tuynman, Niels F. Kok, Simon W. Nienhuijs, and Felice N. van Erning: nothing to disclose. Ignace H.J.T. de Hingh: discloses an unrestricted research grant from RanD\/QPS and Roche, outside the submitted work, paid to the institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}